Metformin Inhibits Tumorigenesis and Tumor Growth of Breast Cancer Cells by Upregulating miR-200c but Downregulating AKT2 Expression

Background: Metformin has been reported to inhibit the growth of various types of cancers, including breast cancer. Yet the mechanisms underlying the anticancer effects of metformin are not fully understood. Growing evidence suggests that metformin's anticancer effects are mediated at least in...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Cancer
Asıl Yazarlar: Zhang, Jiali, Li, Gefei, Chen, Yuan, Fang, Lei, Guan, Chen, Bai, Fumao, Ma, Mengni, Lyu, Jianxin, Meng, Qing H.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Ivyspring International Publisher 2017
Konular:
Research Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5556649/
https://ncbi.nlm.nih.gov/pubmed/28819383
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.19858
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller